Global PD-1 and PDL-1 Inhibitors Production, Demand and Key Producers, 2022-2028
PD-1 inhibitors, including PD-1 antibodies and PD-L1 antibodies, are a new class of immunotherapy drugs. The main mechanism of action is to block the interaction between PD-1 and PD-L1, because the interaction of these two proteins will help tumors escape the pursuit of the immune system, a typical 'helping evil'. PD-1/PD-L1 antibodies, by blocking this 'sinful connection', promote the patient's own immune system to kill tumors.
This report studies the global PD-1 and PDL-1 Inhibitors production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for PD-1 and PDL-1 Inhibitors, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of PD-1 and PDL-1 Inhibitors that contribute to its increasing demand across many markets.
The global PD-1 and PDL-1 Inhibitors market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global PD-1 and PDL-1 Inhibitors total production and demand, 2017-2028, (K Units)
Global PD-1 and PDL-1 Inhibitors total production value, 2017-2028, (USD Million)
Global PD-1 and PDL-1 Inhibitors production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global PD-1 and PDL-1 Inhibitors consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: PD-1 and PDL-1 Inhibitors domestic production, consumption, key domestic manufacturers and share
Global PD-1 and PDL-1 Inhibitors production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global PD-1 and PDL-1 Inhibitors production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global PD-1 and PDL-1 Inhibitors production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global PD-1 and PDL-1 Inhibitors market based on the following parameters – headquarters, production locations, products portfolio, PD-1 and PDL-1 Inhibitors revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World PD-1 and PDL-1 Inhibitors market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global PD-1 and PDL-1 Inhibitors Market, By Region:
1. How big is the global PD-1 and PDL-1 Inhibitors market?
2. What is the demand of the global PD-1 and PDL-1 Inhibitors market?
3. What is the year over year growth of the global PD-1 and PDL-1 Inhibitors market?
4. What is the production and production value of the global PD-1 and PDL-1 Inhibitors market?
5. Who are the key producers in the global PD-1 and PDL-1 Inhibitors market?
6. What are the growth factors driving the market demand?
This report studies the global PD-1 and PDL-1 Inhibitors production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for PD-1 and PDL-1 Inhibitors, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of PD-1 and PDL-1 Inhibitors that contribute to its increasing demand across many markets.
The global PD-1 and PDL-1 Inhibitors market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global PD-1 and PDL-1 Inhibitors total production and demand, 2017-2028, (K Units)
Global PD-1 and PDL-1 Inhibitors total production value, 2017-2028, (USD Million)
Global PD-1 and PDL-1 Inhibitors production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global PD-1 and PDL-1 Inhibitors consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: PD-1 and PDL-1 Inhibitors domestic production, consumption, key domestic manufacturers and share
Global PD-1 and PDL-1 Inhibitors production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global PD-1 and PDL-1 Inhibitors production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global PD-1 and PDL-1 Inhibitors production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global PD-1 and PDL-1 Inhibitors market based on the following parameters – headquarters, production locations, products portfolio, PD-1 and PDL-1 Inhibitors revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World PD-1 and PDL-1 Inhibitors market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global PD-1 and PDL-1 Inhibitors Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Pembrolizumab
- Nivolumab
- Atezolizumab
- Durvalumab
- Avelumab
- Stomach Cancer
- Liver Cancer
- Kidney Ccancer
- Bladder Cancer
- Cervical Cancer
- Other
- GlaxoSmithKline plc
- Bristol-Myers Squibb Company
- Arcus Biosciences, Inc.
- Agenus Inc
- F. Hoffmann-La Roche Ltd
- Astra Zeneca PLC
- Beigene Ltd
- Incyte Corporation
- Biocad
- CStone Pharmaceuticals
- Shanghai Junshi Bioscience Co. Ltd
- Shanghai Henlius Biotech, Inc.
- Jiangsu HengRui Medicine Co., Ltd.
- Lee's Pharmaceutical Limited
1. How big is the global PD-1 and PDL-1 Inhibitors market?
2. What is the demand of the global PD-1 and PDL-1 Inhibitors market?
3. What is the year over year growth of the global PD-1 and PDL-1 Inhibitors market?
4. What is the production and production value of the global PD-1 and PDL-1 Inhibitors market?
5. Who are the key producers in the global PD-1 and PDL-1 Inhibitors market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 PD-1 and PDL-1 Inhibitors Introduction
1.2 World PD-1 and PDL-1 Inhibitors Supply & Forecast
1.2.1 World PD-1 and PDL-1 Inhibitors Production Value (2017 & 2021 & 2028)
1.2.2 World PD-1 and PDL-1 Inhibitors Production (2017-2028)
1.2.3 World PD-1 and PDL-1 Inhibitors Pricing Trends (2017-2028)
1.3 World PD-1 and PDL-1 Inhibitors Production by Region
1.3.1 World PD-1 and PDL-1 Inhibitors Production Value by Region (2017-2028)
1.3.2 World PD-1 and PDL-1 Inhibitors Production by Region (2017-2028)
1.3.3 World PD-1 and PDL-1 Inhibitors Average Price by Region (2017-2028)
1.3.4 North America PD-1 and PDL-1 Inhibitors Production (2017-2028)
1.3.5 Europe PD-1 and PDL-1 Inhibitors Production (2017-2028)
1.3.6 China PD-1 and PDL-1 Inhibitors Production (2017-2028)
1.3.7 Japan PD-1 and PDL-1 Inhibitors Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 PD-1 and PDL-1 Inhibitors Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 PD-1 and PDL-1 Inhibitors Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World PD-1 and PDL-1 Inhibitors Demand (2017-2028)
2.2 World PD-1 and PDL-1 Inhibitors Consumption by Region
2.2.1 World PD-1 and PDL-1 Inhibitors Consumption by Region (2017-2022)
2.2.2 World PD-1 and PDL-1 Inhibitors Consumption Forecast by Region (2023-2028)
2.3 United States PD-1 and PDL-1 Inhibitors Consumption (2017-2028)
2.4 China PD-1 and PDL-1 Inhibitors Consumption (2017-2028)
2.5 Europe PD-1 and PDL-1 Inhibitors Consumption (2017-2028)
2.6 Japan PD-1 and PDL-1 Inhibitors Consumption (2017-2028)
2.7 South Korea PD-1 and PDL-1 Inhibitors Consumption (2017-2028)
2.8 ASEAN PD-1 and PDL-1 Inhibitors Consumption (2017-2028)
2.9 India PD-1 and PDL-1 Inhibitors Consumption (2017-2028)
3 WORLD PD-1 AND PDL-1 INHIBITORS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World PD-1 and PDL-1 Inhibitors Production Value by Manufacturer (2017-2022)
3.2 World PD-1 and PDL-1 Inhibitors Production by Manufacturer (2017-2022)
3.3 World PD-1 and PDL-1 Inhibitors Average Price by Manufacturer (2017-2022)
3.4 PD-1 and PDL-1 Inhibitors Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global PD-1 and PDL-1 Inhibitors Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for PD-1 and PDL-1 Inhibitors in 2021
3.5.3 Global Concentration Ratios (CR8) for PD-1 and PDL-1 Inhibitors in 2021
3.6 PD-1 and PDL-1 Inhibitors Market: Overall Company Footprint Analysis
3.6.1 PD-1 and PDL-1 Inhibitors Market: Region Footprint
3.6.2 PD-1 and PDL-1 Inhibitors Market: Company Product Type Footprint
3.6.3 PD-1 and PDL-1 Inhibitors Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: PD-1 and PDL-1 Inhibitors Production Value Comparison
4.1.1 United States VS China: PD-1 and PDL-1 Inhibitors Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: PD-1 and PDL-1 Inhibitors Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: PD-1 and PDL-1 Inhibitors Production Comparison
4.2.1 United States VS China: PD-1 and PDL-1 Inhibitors Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: PD-1 and PDL-1 Inhibitors Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: PD-1 and PDL-1 Inhibitors Consumption Comparison
4.3.1 United States VS China: PD-1 and PDL-1 Inhibitors Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: PD-1 and PDL-1 Inhibitors Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States PD-1 and PDL-1 Inhibitors Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of PD-1 and PDL-1 Inhibitors in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States PD-1 and PDL-1 Inhibitors Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States PD-1 and PDL-1 Inhibitors Production by Domestic Manufacturer, (2017-2022)
4.5 China PD-1 and PDL-1 Inhibitors Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of PD-1 and PDL-1 Inhibitors in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China PD-1 and PDL-1 Inhibitors Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China PD-1 and PDL-1 Inhibitors Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World PD-1 and PDL-1 Inhibitors Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of PD-1 and PDL-1 Inhibitors in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World PD-1 and PDL-1 Inhibitors Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World PD-1 and PDL-1 Inhibitors Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World PD-1 and PDL-1 Inhibitors Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 Pembrolizumab
5.2.2 Nivolumab
5.2.3 Atezolizumab
5.2.4 Durvalumab
5.2.5 Avelumab
5.3 Market Segment by Type
5.3.1 World PD-1 and PDL-1 Inhibitors Production by Type (2017-2028)
5.3.2 World PD-1 and PDL-1 Inhibitors Production Value by Type (2017-2028)
5.3.3 World PD-1 and PDL-1 Inhibitors Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World PD-1 and PDL-1 Inhibitors Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Stomach Cancer
6.2.2 Liver Cancer
6.2.3 Kidney Ccancer
6.2.4 Bladder Cancer
6.2.5 Cervical Cancer
6.2.6 Other
6.3 Market Segment by Application
6.3.1 World PD-1 and PDL-1 Inhibitors Production by Application (2017-2028)
6.3.2 World PD-1 and PDL-1 Inhibitors Production Value by Application (2017-2028)
6.3.3 World PD-1 and PDL-1 Inhibitors Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 GlaxoSmithKline plc
7.1.1 GlaxoSmithKline plc Details
7.1.2 GlaxoSmithKline plc Major Business
7.1.3 GlaxoSmithKline plc PD-1 and PDL-1 Inhibitors Product and Services
7.1.4 GlaxoSmithKline plc PD-1 and PDL-1 Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 GlaxoSmithKline plc Recent Developments/Updates
7.1.6 GlaxoSmithKline plc Competitive Strengths & Weaknesses
7.2 Bristol-Myers Squibb Company
7.2.1 Bristol-Myers Squibb Company Details
7.2.2 Bristol-Myers Squibb Company Major Business
7.2.3 Bristol-Myers Squibb Company PD-1 and PDL-1 Inhibitors Product and Services
7.2.4 Bristol-Myers Squibb Company PD-1 and PDL-1 Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 Bristol-Myers Squibb Company Recent Developments/Updates
7.2.6 Bristol-Myers Squibb Company Competitive Strengths & Weaknesses
7.3 Arcus Biosciences, Inc.
7.3.1 Arcus Biosciences, Inc. Details
7.3.2 Arcus Biosciences, Inc. Major Business
7.3.3 Arcus Biosciences, Inc. PD-1 and PDL-1 Inhibitors Product and Services
7.3.4 Arcus Biosciences, Inc. PD-1 and PDL-1 Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Arcus Biosciences, Inc. Recent Developments/Updates
7.3.6 Arcus Biosciences, Inc. Competitive Strengths & Weaknesses
7.4 Agenus Inc
7.4.1 Agenus Inc Details
7.4.2 Agenus Inc Major Business
7.4.3 Agenus Inc PD-1 and PDL-1 Inhibitors Product and Services
7.4.4 Agenus Inc PD-1 and PDL-1 Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Agenus Inc Recent Developments/Updates
7.4.6 Agenus Inc Competitive Strengths & Weaknesses
7.5 F. Hoffmann-La Roche Ltd
7.5.1 F. Hoffmann-La Roche Ltd Details
7.5.2 F. Hoffmann-La Roche Ltd Major Business
7.5.3 F. Hoffmann-La Roche Ltd PD-1 and PDL-1 Inhibitors Product and Services
7.5.4 F. Hoffmann-La Roche Ltd PD-1 and PDL-1 Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 F. Hoffmann-La Roche Ltd Recent Developments/Updates
7.5.6 F. Hoffmann-La Roche Ltd Competitive Strengths & Weaknesses
7.6 Astra Zeneca PLC
7.6.1 Astra Zeneca PLC Details
7.6.2 Astra Zeneca PLC Major Business
7.6.3 Astra Zeneca PLC PD-1 and PDL-1 Inhibitors Product and Services
7.6.4 Astra Zeneca PLC PD-1 and PDL-1 Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 Astra Zeneca PLC Recent Developments/Updates
7.6.6 Astra Zeneca PLC Competitive Strengths & Weaknesses
7.7 Beigene Ltd
7.7.1 Beigene Ltd Details
7.7.2 Beigene Ltd Major Business
7.7.3 Beigene Ltd PD-1 and PDL-1 Inhibitors Product and Services
7.7.4 Beigene Ltd PD-1 and PDL-1 Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 Beigene Ltd Recent Developments/Updates
7.7.6 Beigene Ltd Competitive Strengths & Weaknesses
7.8 Incyte Corporation
7.8.1 Incyte Corporation Details
7.8.2 Incyte Corporation Major Business
7.8.3 Incyte Corporation PD-1 and PDL-1 Inhibitors Product and Services
7.8.4 Incyte Corporation PD-1 and PDL-1 Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 Incyte Corporation Recent Developments/Updates
7.8.6 Incyte Corporation Competitive Strengths & Weaknesses
7.9 Biocad
7.9.1 Biocad Details
7.9.2 Biocad Major Business
7.9.3 Biocad PD-1 and PDL-1 Inhibitors Product and Services
7.9.4 Biocad PD-1 and PDL-1 Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 Biocad Recent Developments/Updates
7.9.6 Biocad Competitive Strengths & Weaknesses
7.10 CStone Pharmaceuticals
7.10.1 CStone Pharmaceuticals Details
7.10.2 CStone Pharmaceuticals Major Business
7.10.3 CStone Pharmaceuticals PD-1 and PDL-1 Inhibitors Product and Services
7.10.4 CStone Pharmaceuticals PD-1 and PDL-1 Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 CStone Pharmaceuticals Recent Developments/Updates
7.10.6 CStone Pharmaceuticals Competitive Strengths & Weaknesses
7.11 Shanghai Junshi Bioscience Co. Ltd
7.11.1 Shanghai Junshi Bioscience Co. Ltd Details
7.11.2 Shanghai Junshi Bioscience Co. Ltd Major Business
7.11.3 Shanghai Junshi Bioscience Co. Ltd PD-1 and PDL-1 Inhibitors Product and Services
7.11.4 Shanghai Junshi Bioscience Co. Ltd PD-1 and PDL-1 Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.11.5 Shanghai Junshi Bioscience Co. Ltd Recent Developments/Updates
7.11.6 Shanghai Junshi Bioscience Co. Ltd Competitive Strengths & Weaknesses
7.12 Shanghai Henlius Biotech, Inc.
7.12.1 Shanghai Henlius Biotech, Inc. Details
7.12.2 Shanghai Henlius Biotech, Inc. Major Business
7.12.3 Shanghai Henlius Biotech, Inc. PD-1 and PDL-1 Inhibitors Product and Services
7.12.4 Shanghai Henlius Biotech, Inc. PD-1 and PDL-1 Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.12.5 Shanghai Henlius Biotech, Inc. Recent Developments/Updates
7.12.6 Shanghai Henlius Biotech, Inc. Competitive Strengths & Weaknesses
7.13 Jiangsu HengRui Medicine Co., Ltd.
7.13.1 Jiangsu HengRui Medicine Co., Ltd. Details
7.13.2 Jiangsu HengRui Medicine Co., Ltd. Major Business
7.13.3 Jiangsu HengRui Medicine Co., Ltd. PD-1 and PDL-1 Inhibitors Product and Services
7.13.4 Jiangsu HengRui Medicine Co., Ltd. PD-1 and PDL-1 Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.13.5 Jiangsu HengRui Medicine Co., Ltd. Recent Developments/Updates
7.13.6 Jiangsu HengRui Medicine Co., Ltd. Competitive Strengths & Weaknesses
7.14 Lee's Pharmaceutical Limited
7.14.1 Lee's Pharmaceutical Limited Details
7.14.2 Lee's Pharmaceutical Limited Major Business
7.14.3 Lee's Pharmaceutical Limited PD-1 and PDL-1 Inhibitors Product and Services
7.14.4 Lee's Pharmaceutical Limited PD-1 and PDL-1 Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.14.5 Lee's Pharmaceutical Limited Recent Developments/Updates
7.14.6 Lee's Pharmaceutical Limited Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of PD-1 and PDL-1 Inhibitors and Key Manufacturers
8.2 PD-1 and PDL-1 Inhibitors Manufacturing Costs
8.3 PD-1 and PDL-1 Inhibitors Production Process
8.4 PD-1 and PDL-1 Inhibitors Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for PD-1 and PDL-1 Inhibitors Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 PD-1 and PDL-1 Inhibitors Typical Distributors
9.3 PD-1 and PDL-1 Inhibitors Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
1.1 PD-1 and PDL-1 Inhibitors Introduction
1.2 World PD-1 and PDL-1 Inhibitors Supply & Forecast
1.2.1 World PD-1 and PDL-1 Inhibitors Production Value (2017 & 2021 & 2028)
1.2.2 World PD-1 and PDL-1 Inhibitors Production (2017-2028)
1.2.3 World PD-1 and PDL-1 Inhibitors Pricing Trends (2017-2028)
1.3 World PD-1 and PDL-1 Inhibitors Production by Region
1.3.1 World PD-1 and PDL-1 Inhibitors Production Value by Region (2017-2028)
1.3.2 World PD-1 and PDL-1 Inhibitors Production by Region (2017-2028)
1.3.3 World PD-1 and PDL-1 Inhibitors Average Price by Region (2017-2028)
1.3.4 North America PD-1 and PDL-1 Inhibitors Production (2017-2028)
1.3.5 Europe PD-1 and PDL-1 Inhibitors Production (2017-2028)
1.3.6 China PD-1 and PDL-1 Inhibitors Production (2017-2028)
1.3.7 Japan PD-1 and PDL-1 Inhibitors Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 PD-1 and PDL-1 Inhibitors Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 PD-1 and PDL-1 Inhibitors Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World PD-1 and PDL-1 Inhibitors Demand (2017-2028)
2.2 World PD-1 and PDL-1 Inhibitors Consumption by Region
2.2.1 World PD-1 and PDL-1 Inhibitors Consumption by Region (2017-2022)
2.2.2 World PD-1 and PDL-1 Inhibitors Consumption Forecast by Region (2023-2028)
2.3 United States PD-1 and PDL-1 Inhibitors Consumption (2017-2028)
2.4 China PD-1 and PDL-1 Inhibitors Consumption (2017-2028)
2.5 Europe PD-1 and PDL-1 Inhibitors Consumption (2017-2028)
2.6 Japan PD-1 and PDL-1 Inhibitors Consumption (2017-2028)
2.7 South Korea PD-1 and PDL-1 Inhibitors Consumption (2017-2028)
2.8 ASEAN PD-1 and PDL-1 Inhibitors Consumption (2017-2028)
2.9 India PD-1 and PDL-1 Inhibitors Consumption (2017-2028)
3 WORLD PD-1 AND PDL-1 INHIBITORS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World PD-1 and PDL-1 Inhibitors Production Value by Manufacturer (2017-2022)
3.2 World PD-1 and PDL-1 Inhibitors Production by Manufacturer (2017-2022)
3.3 World PD-1 and PDL-1 Inhibitors Average Price by Manufacturer (2017-2022)
3.4 PD-1 and PDL-1 Inhibitors Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global PD-1 and PDL-1 Inhibitors Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for PD-1 and PDL-1 Inhibitors in 2021
3.5.3 Global Concentration Ratios (CR8) for PD-1 and PDL-1 Inhibitors in 2021
3.6 PD-1 and PDL-1 Inhibitors Market: Overall Company Footprint Analysis
3.6.1 PD-1 and PDL-1 Inhibitors Market: Region Footprint
3.6.2 PD-1 and PDL-1 Inhibitors Market: Company Product Type Footprint
3.6.3 PD-1 and PDL-1 Inhibitors Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: PD-1 and PDL-1 Inhibitors Production Value Comparison
4.1.1 United States VS China: PD-1 and PDL-1 Inhibitors Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: PD-1 and PDL-1 Inhibitors Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: PD-1 and PDL-1 Inhibitors Production Comparison
4.2.1 United States VS China: PD-1 and PDL-1 Inhibitors Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: PD-1 and PDL-1 Inhibitors Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: PD-1 and PDL-1 Inhibitors Consumption Comparison
4.3.1 United States VS China: PD-1 and PDL-1 Inhibitors Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: PD-1 and PDL-1 Inhibitors Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States PD-1 and PDL-1 Inhibitors Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of PD-1 and PDL-1 Inhibitors in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States PD-1 and PDL-1 Inhibitors Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States PD-1 and PDL-1 Inhibitors Production by Domestic Manufacturer, (2017-2022)
4.5 China PD-1 and PDL-1 Inhibitors Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of PD-1 and PDL-1 Inhibitors in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China PD-1 and PDL-1 Inhibitors Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China PD-1 and PDL-1 Inhibitors Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World PD-1 and PDL-1 Inhibitors Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of PD-1 and PDL-1 Inhibitors in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World PD-1 and PDL-1 Inhibitors Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World PD-1 and PDL-1 Inhibitors Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World PD-1 and PDL-1 Inhibitors Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 Pembrolizumab
5.2.2 Nivolumab
5.2.3 Atezolizumab
5.2.4 Durvalumab
5.2.5 Avelumab
5.3 Market Segment by Type
5.3.1 World PD-1 and PDL-1 Inhibitors Production by Type (2017-2028)
5.3.2 World PD-1 and PDL-1 Inhibitors Production Value by Type (2017-2028)
5.3.3 World PD-1 and PDL-1 Inhibitors Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World PD-1 and PDL-1 Inhibitors Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Stomach Cancer
6.2.2 Liver Cancer
6.2.3 Kidney Ccancer
6.2.4 Bladder Cancer
6.2.5 Cervical Cancer
6.2.6 Other
6.3 Market Segment by Application
6.3.1 World PD-1 and PDL-1 Inhibitors Production by Application (2017-2028)
6.3.2 World PD-1 and PDL-1 Inhibitors Production Value by Application (2017-2028)
6.3.3 World PD-1 and PDL-1 Inhibitors Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 GlaxoSmithKline plc
7.1.1 GlaxoSmithKline plc Details
7.1.2 GlaxoSmithKline plc Major Business
7.1.3 GlaxoSmithKline plc PD-1 and PDL-1 Inhibitors Product and Services
7.1.4 GlaxoSmithKline plc PD-1 and PDL-1 Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 GlaxoSmithKline plc Recent Developments/Updates
7.1.6 GlaxoSmithKline plc Competitive Strengths & Weaknesses
7.2 Bristol-Myers Squibb Company
7.2.1 Bristol-Myers Squibb Company Details
7.2.2 Bristol-Myers Squibb Company Major Business
7.2.3 Bristol-Myers Squibb Company PD-1 and PDL-1 Inhibitors Product and Services
7.2.4 Bristol-Myers Squibb Company PD-1 and PDL-1 Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 Bristol-Myers Squibb Company Recent Developments/Updates
7.2.6 Bristol-Myers Squibb Company Competitive Strengths & Weaknesses
7.3 Arcus Biosciences, Inc.
7.3.1 Arcus Biosciences, Inc. Details
7.3.2 Arcus Biosciences, Inc. Major Business
7.3.3 Arcus Biosciences, Inc. PD-1 and PDL-1 Inhibitors Product and Services
7.3.4 Arcus Biosciences, Inc. PD-1 and PDL-1 Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Arcus Biosciences, Inc. Recent Developments/Updates
7.3.6 Arcus Biosciences, Inc. Competitive Strengths & Weaknesses
7.4 Agenus Inc
7.4.1 Agenus Inc Details
7.4.2 Agenus Inc Major Business
7.4.3 Agenus Inc PD-1 and PDL-1 Inhibitors Product and Services
7.4.4 Agenus Inc PD-1 and PDL-1 Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Agenus Inc Recent Developments/Updates
7.4.6 Agenus Inc Competitive Strengths & Weaknesses
7.5 F. Hoffmann-La Roche Ltd
7.5.1 F. Hoffmann-La Roche Ltd Details
7.5.2 F. Hoffmann-La Roche Ltd Major Business
7.5.3 F. Hoffmann-La Roche Ltd PD-1 and PDL-1 Inhibitors Product and Services
7.5.4 F. Hoffmann-La Roche Ltd PD-1 and PDL-1 Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 F. Hoffmann-La Roche Ltd Recent Developments/Updates
7.5.6 F. Hoffmann-La Roche Ltd Competitive Strengths & Weaknesses
7.6 Astra Zeneca PLC
7.6.1 Astra Zeneca PLC Details
7.6.2 Astra Zeneca PLC Major Business
7.6.3 Astra Zeneca PLC PD-1 and PDL-1 Inhibitors Product and Services
7.6.4 Astra Zeneca PLC PD-1 and PDL-1 Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 Astra Zeneca PLC Recent Developments/Updates
7.6.6 Astra Zeneca PLC Competitive Strengths & Weaknesses
7.7 Beigene Ltd
7.7.1 Beigene Ltd Details
7.7.2 Beigene Ltd Major Business
7.7.3 Beigene Ltd PD-1 and PDL-1 Inhibitors Product and Services
7.7.4 Beigene Ltd PD-1 and PDL-1 Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 Beigene Ltd Recent Developments/Updates
7.7.6 Beigene Ltd Competitive Strengths & Weaknesses
7.8 Incyte Corporation
7.8.1 Incyte Corporation Details
7.8.2 Incyte Corporation Major Business
7.8.3 Incyte Corporation PD-1 and PDL-1 Inhibitors Product and Services
7.8.4 Incyte Corporation PD-1 and PDL-1 Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 Incyte Corporation Recent Developments/Updates
7.8.6 Incyte Corporation Competitive Strengths & Weaknesses
7.9 Biocad
7.9.1 Biocad Details
7.9.2 Biocad Major Business
7.9.3 Biocad PD-1 and PDL-1 Inhibitors Product and Services
7.9.4 Biocad PD-1 and PDL-1 Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 Biocad Recent Developments/Updates
7.9.6 Biocad Competitive Strengths & Weaknesses
7.10 CStone Pharmaceuticals
7.10.1 CStone Pharmaceuticals Details
7.10.2 CStone Pharmaceuticals Major Business
7.10.3 CStone Pharmaceuticals PD-1 and PDL-1 Inhibitors Product and Services
7.10.4 CStone Pharmaceuticals PD-1 and PDL-1 Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 CStone Pharmaceuticals Recent Developments/Updates
7.10.6 CStone Pharmaceuticals Competitive Strengths & Weaknesses
7.11 Shanghai Junshi Bioscience Co. Ltd
7.11.1 Shanghai Junshi Bioscience Co. Ltd Details
7.11.2 Shanghai Junshi Bioscience Co. Ltd Major Business
7.11.3 Shanghai Junshi Bioscience Co. Ltd PD-1 and PDL-1 Inhibitors Product and Services
7.11.4 Shanghai Junshi Bioscience Co. Ltd PD-1 and PDL-1 Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.11.5 Shanghai Junshi Bioscience Co. Ltd Recent Developments/Updates
7.11.6 Shanghai Junshi Bioscience Co. Ltd Competitive Strengths & Weaknesses
7.12 Shanghai Henlius Biotech, Inc.
7.12.1 Shanghai Henlius Biotech, Inc. Details
7.12.2 Shanghai Henlius Biotech, Inc. Major Business
7.12.3 Shanghai Henlius Biotech, Inc. PD-1 and PDL-1 Inhibitors Product and Services
7.12.4 Shanghai Henlius Biotech, Inc. PD-1 and PDL-1 Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.12.5 Shanghai Henlius Biotech, Inc. Recent Developments/Updates
7.12.6 Shanghai Henlius Biotech, Inc. Competitive Strengths & Weaknesses
7.13 Jiangsu HengRui Medicine Co., Ltd.
7.13.1 Jiangsu HengRui Medicine Co., Ltd. Details
7.13.2 Jiangsu HengRui Medicine Co., Ltd. Major Business
7.13.3 Jiangsu HengRui Medicine Co., Ltd. PD-1 and PDL-1 Inhibitors Product and Services
7.13.4 Jiangsu HengRui Medicine Co., Ltd. PD-1 and PDL-1 Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.13.5 Jiangsu HengRui Medicine Co., Ltd. Recent Developments/Updates
7.13.6 Jiangsu HengRui Medicine Co., Ltd. Competitive Strengths & Weaknesses
7.14 Lee's Pharmaceutical Limited
7.14.1 Lee's Pharmaceutical Limited Details
7.14.2 Lee's Pharmaceutical Limited Major Business
7.14.3 Lee's Pharmaceutical Limited PD-1 and PDL-1 Inhibitors Product and Services
7.14.4 Lee's Pharmaceutical Limited PD-1 and PDL-1 Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.14.5 Lee's Pharmaceutical Limited Recent Developments/Updates
7.14.6 Lee's Pharmaceutical Limited Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of PD-1 and PDL-1 Inhibitors and Key Manufacturers
8.2 PD-1 and PDL-1 Inhibitors Manufacturing Costs
8.3 PD-1 and PDL-1 Inhibitors Production Process
8.4 PD-1 and PDL-1 Inhibitors Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for PD-1 and PDL-1 Inhibitors Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 PD-1 and PDL-1 Inhibitors Typical Distributors
9.3 PD-1 and PDL-1 Inhibitors Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
LIST OF TABLES
Table 1. World PD-1 and PDL-1 Inhibitors Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World PD-1 and PDL-1 Inhibitors Production Value by Region (2017-2022) & (USD Million)
Table 3. World PD-1 and PDL-1 Inhibitors Production Value by Region (2023-2028) & (USD Million)
Table 4. World PD-1 and PDL-1 Inhibitors Production Value Market Share by Region (2017-2022)
Table 5. World PD-1 and PDL-1 Inhibitors Production Value Market Share by Region (2023-2028)
Table 6. World PD-1 and PDL-1 Inhibitors Production by Region (2017-2022) & (K Units)
Table 7. World PD-1 and PDL-1 Inhibitors Production by Region (2023-2028) & (K Units)
Table 8. World PD-1 and PDL-1 Inhibitors Production Market Share by Region (2017-2022)
Table 9. World PD-1 and PDL-1 Inhibitors Production Market Share by Region (2023-2028)
Table 10. World PD-1 and PDL-1 Inhibitors Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World PD-1 and PDL-1 Inhibitors Average Price by Region (2023-2028) & (US$/Unit)
Table 12. PD-1 and PDL-1 Inhibitors Major Market Trends
Table 13. World PD-1 and PDL-1 Inhibitors Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World PD-1 and PDL-1 Inhibitors Consumption by Region (2017-2022) & (K Units)
Table 15. World PD-1 and PDL-1 Inhibitors Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World PD-1 and PDL-1 Inhibitors Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key PD-1 and PDL-1 Inhibitors Producers in 2021
Table 18. World PD-1 and PDL-1 Inhibitors Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key PD-1 and PDL-1 Inhibitors Producers in 2021
Table 20. World PD-1 and PDL-1 Inhibitors Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global PD-1 and PDL-1 Inhibitors Company Evaluation Quadrant
Table 22. World PD-1 and PDL-1 Inhibitors Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and PD-1 and PDL-1 Inhibitors Production Site of Key Manufacturer
Table 24. PD-1 and PDL-1 Inhibitors Market: Company Product Type Footprint
Table 25. PD-1 and PDL-1 Inhibitors Market: Company Product Application Footprint
Table 26. PD-1 and PDL-1 Inhibitors Competitive Factors
Table 27. PD-1 and PDL-1 Inhibitors New Entrant and Capacity Expansion Plans
Table 28. PD-1 and PDL-1 Inhibitors Mergers & Acquisitions Activity
Table 29. United States VS China PD-1 and PDL-1 Inhibitors Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China PD-1 and PDL-1 Inhibitors Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China PD-1 and PDL-1 Inhibitors Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of PD-1 and PDL-1 Inhibitors in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States PD-1 and PDL-1 Inhibitors Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States PD-1 and PDL-1 Inhibitors Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States PD-1 and PDL-1 Inhibitors Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States PD-1 and PDL-1 Inhibitors Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of PD-1 and PDL-1 Inhibitors in China, Company Headquarters and Production Place (Province, Country)
Table 38. China PD-1 and PDL-1 Inhibitors Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China PD-1 and PDL-1 Inhibitors Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China PD-1 and PDL-1 Inhibitors Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China PD-1 and PDL-1 Inhibitors Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of PD-1 and PDL-1 Inhibitors in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World PD-1 and PDL-1 Inhibitors Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World PD-1 and PDL-1 Inhibitors Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World PD-1 and PDL-1 Inhibitors Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World PD-1 and PDL-1 Inhibitors Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World PD-1 and PDL-1 Inhibitors Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World PD-1 and PDL-1 Inhibitors Production by Type (2017-2022) & (K Units)
Table 49. World PD-1 and PDL-1 Inhibitors Production by Type (2023-2028) & (K Units)
Table 50. World PD-1 and PDL-1 Inhibitors Production Value by Type (2017-2022) & (USD Million)
Table 51. World PD-1 and PDL-1 Inhibitors Production Value by Type (2023-2028) & (USD Million)
Table 52. World PD-1 and PDL-1 Inhibitors Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World PD-1 and PDL-1 Inhibitors Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World PD-1 and PDL-1 Inhibitors Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World PD-1 and PDL-1 Inhibitors Production by Application (2017-2022) & (K Units)
Table 56. World PD-1 and PDL-1 Inhibitors Production by Application (2023-2028) & (K Units)
Table 57. World PD-1 and PDL-1 Inhibitors Production Value by Application (2017-2022) & (USD Million)
Table 58. World PD-1 and PDL-1 Inhibitors Production Value by Application (2023-2028) & (USD Million)
Table 59. World PD-1 and PDL-1 Inhibitors Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World PD-1 and PDL-1 Inhibitors Average Price by Application (2023-2028) & (US$/Unit)
Table 61. GlaxoSmithKline plc Basic Information, Manufacturing Base and Competitors
Table 62. GlaxoSmithKline plc Major Business
Table 63. GlaxoSmithKline plc PD-1 and PDL-1 Inhibitors Product and Services
Table 64. GlaxoSmithKline plc PD-1 and PDL-1 Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. GlaxoSmithKline plc Recent Developments/Updates
Table 66. GlaxoSmithKline plc Competitive Strengths & Weaknesses
Table 67. Bristol-Myers Squibb Company Basic Information, Manufacturing Base and Competitors
Table 68. Bristol-Myers Squibb Company Major Business
Table 69. Bristol-Myers Squibb Company PD-1 and PDL-1 Inhibitors Product and Services
Table 70. Bristol-Myers Squibb Company PD-1 and PDL-1 Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. Bristol-Myers Squibb Company Recent Developments/Updates
Table 72. Bristol-Myers Squibb Company Competitive Strengths & Weaknesses
Table 73. Arcus Biosciences, Inc. Basic Information, Manufacturing Base and Competitors
Table 74. Arcus Biosciences, Inc. Major Business
Table 75. Arcus Biosciences, Inc. PD-1 and PDL-1 Inhibitors Product and Services
Table 76. Arcus Biosciences, Inc. PD-1 and PDL-1 Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Arcus Biosciences, Inc. Recent Developments/Updates
Table 78. Arcus Biosciences, Inc. Competitive Strengths & Weaknesses
Table 79. Agenus Inc Basic Information, Manufacturing Base and Competitors
Table 80. Agenus Inc Major Business
Table 81. Agenus Inc PD-1 and PDL-1 Inhibitors Product and Services
Table 82. Agenus Inc PD-1 and PDL-1 Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Agenus Inc Recent Developments/Updates
Table 84. Agenus Inc Competitive Strengths & Weaknesses
Table 85. F. Hoffmann-La Roche Ltd Basic Information, Manufacturing Base and Competitors
Table 86. F. Hoffmann-La Roche Ltd Major Business
Table 87. F. Hoffmann-La Roche Ltd PD-1 and PDL-1 Inhibitors Product and Services
Table 88. F. Hoffmann-La Roche Ltd PD-1 and PDL-1 Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. F. Hoffmann-La Roche Ltd Recent Developments/Updates
Table 90. F. Hoffmann-La Roche Ltd Competitive Strengths & Weaknesses
Table 91. Astra Zeneca PLC Basic Information, Manufacturing Base and Competitors
Table 92. Astra Zeneca PLC Major Business
Table 93. Astra Zeneca PLC PD-1 and PDL-1 Inhibitors Product and Services
Table 94. Astra Zeneca PLC PD-1 and PDL-1 Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. Astra Zeneca PLC Recent Developments/Updates
Table 96. Astra Zeneca PLC Competitive Strengths & Weaknesses
Table 97. Beigene Ltd Basic Information, Manufacturing Base and Competitors
Table 98. Beigene Ltd Major Business
Table 99. Beigene Ltd PD-1 and PDL-1 Inhibitors Product and Services
Table 100. Beigene Ltd PD-1 and PDL-1 Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. Beigene Ltd Recent Developments/Updates
Table 102. Beigene Ltd Competitive Strengths & Weaknesses
Table 103. Incyte Corporation Basic Information, Manufacturing Base and Competitors
Table 104. Incyte Corporation Major Business
Table 105. Incyte Corporation PD-1 and PDL-1 Inhibitors Product and Services
Table 106. Incyte Corporation PD-1 and PDL-1 Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. Incyte Corporation Recent Developments/Updates
Table 108. Incyte Corporation Competitive Strengths & Weaknesses
Table 109. Biocad Basic Information, Manufacturing Base and Competitors
Table 110. Biocad Major Business
Table 111. Biocad PD-1 and PDL-1 Inhibitors Product and Services
Table 112. Biocad PD-1 and PDL-1 Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. Biocad Recent Developments/Updates
Table 114. Biocad Competitive Strengths & Weaknesses
Table 115. CStone Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 116. CStone Pharmaceuticals Major Business
Table 117. CStone Pharmaceuticals PD-1 and PDL-1 Inhibitors Product and Services
Table 118. CStone Pharmaceuticals PD-1 and PDL-1 Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. CStone Pharmaceuticals Recent Developments/Updates
Table 120. CStone Pharmaceuticals Competitive Strengths & Weaknesses
Table 121. Shanghai Junshi Bioscience Co. Ltd Basic Information, Manufacturing Base and Competitors
Table 122. Shanghai Junshi Bioscience Co. Ltd Major Business
Table 123. Shanghai Junshi Bioscience Co. Ltd PD-1 and PDL-1 Inhibitors Product and Services
Table 124. Shanghai Junshi Bioscience Co. Ltd PD-1 and PDL-1 Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 125. Shanghai Junshi Bioscience Co. Ltd Recent Developments/Updates
Table 126. Shanghai Junshi Bioscience Co. Ltd Competitive Strengths & Weaknesses
Table 127. Shanghai Henlius Biotech, Inc. Basic Information, Manufacturing Base and Competitors
Table 128. Shanghai Henlius Biotech, Inc. Major Business
Table 129. Shanghai Henlius Biotech, Inc. PD-1 and PDL-1 Inhibitors Product and Services
Table 130. Shanghai Henlius Biotech, Inc. PD-1 and PDL-1 Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 131. Shanghai Henlius Biotech, Inc. Recent Developments/Updates
Table 132. Shanghai Henlius Biotech, Inc. Competitive Strengths & Weaknesses
Table 133. Jiangsu HengRui Medicine Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 134. Jiangsu HengRui Medicine Co., Ltd. Major Business
Table 135. Jiangsu HengRui Medicine Co., Ltd. PD-1 and PDL-1 Inhibitors Product and Services
Table 136. Jiangsu HengRui Medicine Co., Ltd. PD-1 and PDL-1 Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 137. Jiangsu HengRui Medicine Co., Ltd. Recent Developments/Updates
Table 138. Lee's Pharmaceutical Limited Basic Information, Manufacturing Base and Competitors
Table 139. Lee's Pharmaceutical Limited Major Business
Table 140. Lee's Pharmaceutical Limited PD-1 and PDL-1 Inhibitors Product and Services
Table 141. Lee's Pharmaceutical Limited PD-1 and PDL-1 Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 142. PD-1 and PDL-1 Inhibitors Raw Material
Table 143. Key Manufacturers of PD-1 and PDL-1 Inhibitors Raw Materials
Table 144. PD-1 and PDL-1 Inhibitors Typical Distributors
Table 145. PD-1 and PDL-1 Inhibitors Typical Customers
Table 1. World PD-1 and PDL-1 Inhibitors Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World PD-1 and PDL-1 Inhibitors Production Value by Region (2017-2022) & (USD Million)
Table 3. World PD-1 and PDL-1 Inhibitors Production Value by Region (2023-2028) & (USD Million)
Table 4. World PD-1 and PDL-1 Inhibitors Production Value Market Share by Region (2017-2022)
Table 5. World PD-1 and PDL-1 Inhibitors Production Value Market Share by Region (2023-2028)
Table 6. World PD-1 and PDL-1 Inhibitors Production by Region (2017-2022) & (K Units)
Table 7. World PD-1 and PDL-1 Inhibitors Production by Region (2023-2028) & (K Units)
Table 8. World PD-1 and PDL-1 Inhibitors Production Market Share by Region (2017-2022)
Table 9. World PD-1 and PDL-1 Inhibitors Production Market Share by Region (2023-2028)
Table 10. World PD-1 and PDL-1 Inhibitors Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World PD-1 and PDL-1 Inhibitors Average Price by Region (2023-2028) & (US$/Unit)
Table 12. PD-1 and PDL-1 Inhibitors Major Market Trends
Table 13. World PD-1 and PDL-1 Inhibitors Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World PD-1 and PDL-1 Inhibitors Consumption by Region (2017-2022) & (K Units)
Table 15. World PD-1 and PDL-1 Inhibitors Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World PD-1 and PDL-1 Inhibitors Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key PD-1 and PDL-1 Inhibitors Producers in 2021
Table 18. World PD-1 and PDL-1 Inhibitors Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key PD-1 and PDL-1 Inhibitors Producers in 2021
Table 20. World PD-1 and PDL-1 Inhibitors Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global PD-1 and PDL-1 Inhibitors Company Evaluation Quadrant
Table 22. World PD-1 and PDL-1 Inhibitors Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and PD-1 and PDL-1 Inhibitors Production Site of Key Manufacturer
Table 24. PD-1 and PDL-1 Inhibitors Market: Company Product Type Footprint
Table 25. PD-1 and PDL-1 Inhibitors Market: Company Product Application Footprint
Table 26. PD-1 and PDL-1 Inhibitors Competitive Factors
Table 27. PD-1 and PDL-1 Inhibitors New Entrant and Capacity Expansion Plans
Table 28. PD-1 and PDL-1 Inhibitors Mergers & Acquisitions Activity
Table 29. United States VS China PD-1 and PDL-1 Inhibitors Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China PD-1 and PDL-1 Inhibitors Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China PD-1 and PDL-1 Inhibitors Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of PD-1 and PDL-1 Inhibitors in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States PD-1 and PDL-1 Inhibitors Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States PD-1 and PDL-1 Inhibitors Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States PD-1 and PDL-1 Inhibitors Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States PD-1 and PDL-1 Inhibitors Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of PD-1 and PDL-1 Inhibitors in China, Company Headquarters and Production Place (Province, Country)
Table 38. China PD-1 and PDL-1 Inhibitors Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China PD-1 and PDL-1 Inhibitors Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China PD-1 and PDL-1 Inhibitors Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China PD-1 and PDL-1 Inhibitors Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of PD-1 and PDL-1 Inhibitors in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World PD-1 and PDL-1 Inhibitors Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World PD-1 and PDL-1 Inhibitors Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World PD-1 and PDL-1 Inhibitors Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World PD-1 and PDL-1 Inhibitors Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World PD-1 and PDL-1 Inhibitors Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World PD-1 and PDL-1 Inhibitors Production by Type (2017-2022) & (K Units)
Table 49. World PD-1 and PDL-1 Inhibitors Production by Type (2023-2028) & (K Units)
Table 50. World PD-1 and PDL-1 Inhibitors Production Value by Type (2017-2022) & (USD Million)
Table 51. World PD-1 and PDL-1 Inhibitors Production Value by Type (2023-2028) & (USD Million)
Table 52. World PD-1 and PDL-1 Inhibitors Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World PD-1 and PDL-1 Inhibitors Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World PD-1 and PDL-1 Inhibitors Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World PD-1 and PDL-1 Inhibitors Production by Application (2017-2022) & (K Units)
Table 56. World PD-1 and PDL-1 Inhibitors Production by Application (2023-2028) & (K Units)
Table 57. World PD-1 and PDL-1 Inhibitors Production Value by Application (2017-2022) & (USD Million)
Table 58. World PD-1 and PDL-1 Inhibitors Production Value by Application (2023-2028) & (USD Million)
Table 59. World PD-1 and PDL-1 Inhibitors Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World PD-1 and PDL-1 Inhibitors Average Price by Application (2023-2028) & (US$/Unit)
Table 61. GlaxoSmithKline plc Basic Information, Manufacturing Base and Competitors
Table 62. GlaxoSmithKline plc Major Business
Table 63. GlaxoSmithKline plc PD-1 and PDL-1 Inhibitors Product and Services
Table 64. GlaxoSmithKline plc PD-1 and PDL-1 Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. GlaxoSmithKline plc Recent Developments/Updates
Table 66. GlaxoSmithKline plc Competitive Strengths & Weaknesses
Table 67. Bristol-Myers Squibb Company Basic Information, Manufacturing Base and Competitors
Table 68. Bristol-Myers Squibb Company Major Business
Table 69. Bristol-Myers Squibb Company PD-1 and PDL-1 Inhibitors Product and Services
Table 70. Bristol-Myers Squibb Company PD-1 and PDL-1 Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. Bristol-Myers Squibb Company Recent Developments/Updates
Table 72. Bristol-Myers Squibb Company Competitive Strengths & Weaknesses
Table 73. Arcus Biosciences, Inc. Basic Information, Manufacturing Base and Competitors
Table 74. Arcus Biosciences, Inc. Major Business
Table 75. Arcus Biosciences, Inc. PD-1 and PDL-1 Inhibitors Product and Services
Table 76. Arcus Biosciences, Inc. PD-1 and PDL-1 Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Arcus Biosciences, Inc. Recent Developments/Updates
Table 78. Arcus Biosciences, Inc. Competitive Strengths & Weaknesses
Table 79. Agenus Inc Basic Information, Manufacturing Base and Competitors
Table 80. Agenus Inc Major Business
Table 81. Agenus Inc PD-1 and PDL-1 Inhibitors Product and Services
Table 82. Agenus Inc PD-1 and PDL-1 Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Agenus Inc Recent Developments/Updates
Table 84. Agenus Inc Competitive Strengths & Weaknesses
Table 85. F. Hoffmann-La Roche Ltd Basic Information, Manufacturing Base and Competitors
Table 86. F. Hoffmann-La Roche Ltd Major Business
Table 87. F. Hoffmann-La Roche Ltd PD-1 and PDL-1 Inhibitors Product and Services
Table 88. F. Hoffmann-La Roche Ltd PD-1 and PDL-1 Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. F. Hoffmann-La Roche Ltd Recent Developments/Updates
Table 90. F. Hoffmann-La Roche Ltd Competitive Strengths & Weaknesses
Table 91. Astra Zeneca PLC Basic Information, Manufacturing Base and Competitors
Table 92. Astra Zeneca PLC Major Business
Table 93. Astra Zeneca PLC PD-1 and PDL-1 Inhibitors Product and Services
Table 94. Astra Zeneca PLC PD-1 and PDL-1 Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. Astra Zeneca PLC Recent Developments/Updates
Table 96. Astra Zeneca PLC Competitive Strengths & Weaknesses
Table 97. Beigene Ltd Basic Information, Manufacturing Base and Competitors
Table 98. Beigene Ltd Major Business
Table 99. Beigene Ltd PD-1 and PDL-1 Inhibitors Product and Services
Table 100. Beigene Ltd PD-1 and PDL-1 Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. Beigene Ltd Recent Developments/Updates
Table 102. Beigene Ltd Competitive Strengths & Weaknesses
Table 103. Incyte Corporation Basic Information, Manufacturing Base and Competitors
Table 104. Incyte Corporation Major Business
Table 105. Incyte Corporation PD-1 and PDL-1 Inhibitors Product and Services
Table 106. Incyte Corporation PD-1 and PDL-1 Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. Incyte Corporation Recent Developments/Updates
Table 108. Incyte Corporation Competitive Strengths & Weaknesses
Table 109. Biocad Basic Information, Manufacturing Base and Competitors
Table 110. Biocad Major Business
Table 111. Biocad PD-1 and PDL-1 Inhibitors Product and Services
Table 112. Biocad PD-1 and PDL-1 Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. Biocad Recent Developments/Updates
Table 114. Biocad Competitive Strengths & Weaknesses
Table 115. CStone Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 116. CStone Pharmaceuticals Major Business
Table 117. CStone Pharmaceuticals PD-1 and PDL-1 Inhibitors Product and Services
Table 118. CStone Pharmaceuticals PD-1 and PDL-1 Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. CStone Pharmaceuticals Recent Developments/Updates
Table 120. CStone Pharmaceuticals Competitive Strengths & Weaknesses
Table 121. Shanghai Junshi Bioscience Co. Ltd Basic Information, Manufacturing Base and Competitors
Table 122. Shanghai Junshi Bioscience Co. Ltd Major Business
Table 123. Shanghai Junshi Bioscience Co. Ltd PD-1 and PDL-1 Inhibitors Product and Services
Table 124. Shanghai Junshi Bioscience Co. Ltd PD-1 and PDL-1 Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 125. Shanghai Junshi Bioscience Co. Ltd Recent Developments/Updates
Table 126. Shanghai Junshi Bioscience Co. Ltd Competitive Strengths & Weaknesses
Table 127. Shanghai Henlius Biotech, Inc. Basic Information, Manufacturing Base and Competitors
Table 128. Shanghai Henlius Biotech, Inc. Major Business
Table 129. Shanghai Henlius Biotech, Inc. PD-1 and PDL-1 Inhibitors Product and Services
Table 130. Shanghai Henlius Biotech, Inc. PD-1 and PDL-1 Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 131. Shanghai Henlius Biotech, Inc. Recent Developments/Updates
Table 132. Shanghai Henlius Biotech, Inc. Competitive Strengths & Weaknesses
Table 133. Jiangsu HengRui Medicine Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 134. Jiangsu HengRui Medicine Co., Ltd. Major Business
Table 135. Jiangsu HengRui Medicine Co., Ltd. PD-1 and PDL-1 Inhibitors Product and Services
Table 136. Jiangsu HengRui Medicine Co., Ltd. PD-1 and PDL-1 Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 137. Jiangsu HengRui Medicine Co., Ltd. Recent Developments/Updates
Table 138. Lee's Pharmaceutical Limited Basic Information, Manufacturing Base and Competitors
Table 139. Lee's Pharmaceutical Limited Major Business
Table 140. Lee's Pharmaceutical Limited PD-1 and PDL-1 Inhibitors Product and Services
Table 141. Lee's Pharmaceutical Limited PD-1 and PDL-1 Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 142. PD-1 and PDL-1 Inhibitors Raw Material
Table 143. Key Manufacturers of PD-1 and PDL-1 Inhibitors Raw Materials
Table 144. PD-1 and PDL-1 Inhibitors Typical Distributors
Table 145. PD-1 and PDL-1 Inhibitors Typical Customers
LIST OF FIGURES
Figure 1. PD-1 and PDL-1 Inhibitors Picture
Figure 2. World PD-1 and PDL-1 Inhibitors Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World PD-1 and PDL-1 Inhibitors Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World PD-1 and PDL-1 Inhibitors Production (2017-2028) & (K Units)
Figure 5. World PD-1 and PDL-1 Inhibitors Average Price (2017-2028) & (US$/Unit)
Figure 6. World PD-1 and PDL-1 Inhibitors Production Value Market Share by Region (2017-2028)
Figure 7. World PD-1 and PDL-1 Inhibitors Production Market Share by Region (2017-2028)
Figure 8. North America PD-1 and PDL-1 Inhibitors Production (2017-2028) & (K Units)
Figure 9. Europe PD-1 and PDL-1 Inhibitors Production (2017-2028) & (K Units)
Figure 10. China PD-1 and PDL-1 Inhibitors Production (2017-2028) & (K Units)
Figure 11. Japan PD-1 and PDL-1 Inhibitors Production (2017-2028) & (K Units)
Figure 12. PD-1 and PDL-1 Inhibitors Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World PD-1 and PDL-1 Inhibitors Demand (2017-2028) & (K Units)
Figure 15. World PD-1 and PDL-1 Inhibitors Consumption Market Share by Region (2017-2028)
Figure 16. United States PD-1 and PDL-1 Inhibitors Consumption (2017-2028) & (K Units)
Figure 17. China PD-1 and PDL-1 Inhibitors Consumption (2017-2028) & (K Units)
Figure 18. Europe PD-1 and PDL-1 Inhibitors Consumption (2017-2028) & (K Units)
Figure 19. Japan PD-1 and PDL-1 Inhibitors Consumption (2017-2028) & (K Units)
Figure 20. South Korea PD-1 and PDL-1 Inhibitors Consumption (2017-2028) & (K Units)
Figure 21. ASEAN PD-1 and PDL-1 Inhibitors Consumption (2017-2028) & (K Units)
Figure 22. India PD-1 and PDL-1 Inhibitors Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of PD-1 and PDL-1 Inhibitors by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for PD-1 and PDL-1 Inhibitors Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for PD-1 and PDL-1 Inhibitors Markets in 2021
Figure 26. United States VS China: PD-1 and PDL-1 Inhibitors Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: PD-1 and PDL-1 Inhibitors Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: PD-1 and PDL-1 Inhibitors Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of PD-1 and PDL-1 Inhibitors in United States
Figure 30. Key Producers and Market Share of PD-1 and PDL-1 Inhibitors in China
Figure 31. Key Producers and Market Share of PD-1 and PDL-1 Inhibitors in Rest of World
Figure 32. World PD-1 and PDL-1 Inhibitors Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World PD-1 and PDL-1 Inhibitors Production Value Market Share by Type in 2021
Figure 34. Pembrolizumab
Figure 35. Nivolumab
Figure 36. Atezolizumab
Figure 37. Durvalumab
Figure 38. Avelumab
Figure 39. World PD-1 and PDL-1 Inhibitors Production Market Share by Type (2017-2028)
Figure 40. World PD-1 and PDL-1 Inhibitors Production Value Market Share by Type (2017-2028)
Figure 41. World PD-1 and PDL-1 Inhibitors Average Price by Type (2017-2028) & (US$/Unit)
Figure 42. World PD-1 and PDL-1 Inhibitors Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 43. World PD-1 and PDL-1 Inhibitors Production Value Market Share by Application in 2021
Figure 44. Stomach Cancer
Figure 45. Liver Cancer
Figure 46. Kidney Ccancer
Figure 47. Bladder Cancer
Figure 48. Cervical Cancer
Figure 49. Other
Figure 50. World PD-1 and PDL-1 Inhibitors Production Market Share by Application (2017-2028)
Figure 51. World PD-1 and PDL-1 Inhibitors Production Value Market Share by Application (2017-2028)
Figure 52. World PD-1 and PDL-1 Inhibitors Average Price by Application (2017-2028) & (US$/Unit)
Figure 53. Manufacturing Cost Structure Analysis of PD-1 and PDL-1 Inhibitors in 2021
Figure 54. Manufacturing Process Analysis of PD-1 and PDL-1 Inhibitors
Figure 55. PD-1 and PDL-1 Inhibitors Industrial Chain
Figure 56. Distribution Channel Breakdown for PD-1 and PDL-1 Inhibitors Shipments (%): 2017-2028
Figure 57. Direct Channel Pros & Cons
Figure 58. Indirect Channel Pros & Cons
Figure 59. Methodology
Figure 60. Research Process and Data Source
Figure 1. PD-1 and PDL-1 Inhibitors Picture
Figure 2. World PD-1 and PDL-1 Inhibitors Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World PD-1 and PDL-1 Inhibitors Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World PD-1 and PDL-1 Inhibitors Production (2017-2028) & (K Units)
Figure 5. World PD-1 and PDL-1 Inhibitors Average Price (2017-2028) & (US$/Unit)
Figure 6. World PD-1 and PDL-1 Inhibitors Production Value Market Share by Region (2017-2028)
Figure 7. World PD-1 and PDL-1 Inhibitors Production Market Share by Region (2017-2028)
Figure 8. North America PD-1 and PDL-1 Inhibitors Production (2017-2028) & (K Units)
Figure 9. Europe PD-1 and PDL-1 Inhibitors Production (2017-2028) & (K Units)
Figure 10. China PD-1 and PDL-1 Inhibitors Production (2017-2028) & (K Units)
Figure 11. Japan PD-1 and PDL-1 Inhibitors Production (2017-2028) & (K Units)
Figure 12. PD-1 and PDL-1 Inhibitors Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World PD-1 and PDL-1 Inhibitors Demand (2017-2028) & (K Units)
Figure 15. World PD-1 and PDL-1 Inhibitors Consumption Market Share by Region (2017-2028)
Figure 16. United States PD-1 and PDL-1 Inhibitors Consumption (2017-2028) & (K Units)
Figure 17. China PD-1 and PDL-1 Inhibitors Consumption (2017-2028) & (K Units)
Figure 18. Europe PD-1 and PDL-1 Inhibitors Consumption (2017-2028) & (K Units)
Figure 19. Japan PD-1 and PDL-1 Inhibitors Consumption (2017-2028) & (K Units)
Figure 20. South Korea PD-1 and PDL-1 Inhibitors Consumption (2017-2028) & (K Units)
Figure 21. ASEAN PD-1 and PDL-1 Inhibitors Consumption (2017-2028) & (K Units)
Figure 22. India PD-1 and PDL-1 Inhibitors Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of PD-1 and PDL-1 Inhibitors by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for PD-1 and PDL-1 Inhibitors Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for PD-1 and PDL-1 Inhibitors Markets in 2021
Figure 26. United States VS China: PD-1 and PDL-1 Inhibitors Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: PD-1 and PDL-1 Inhibitors Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: PD-1 and PDL-1 Inhibitors Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of PD-1 and PDL-1 Inhibitors in United States
Figure 30. Key Producers and Market Share of PD-1 and PDL-1 Inhibitors in China
Figure 31. Key Producers and Market Share of PD-1 and PDL-1 Inhibitors in Rest of World
Figure 32. World PD-1 and PDL-1 Inhibitors Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World PD-1 and PDL-1 Inhibitors Production Value Market Share by Type in 2021
Figure 34. Pembrolizumab
Figure 35. Nivolumab
Figure 36. Atezolizumab
Figure 37. Durvalumab
Figure 38. Avelumab
Figure 39. World PD-1 and PDL-1 Inhibitors Production Market Share by Type (2017-2028)
Figure 40. World PD-1 and PDL-1 Inhibitors Production Value Market Share by Type (2017-2028)
Figure 41. World PD-1 and PDL-1 Inhibitors Average Price by Type (2017-2028) & (US$/Unit)
Figure 42. World PD-1 and PDL-1 Inhibitors Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 43. World PD-1 and PDL-1 Inhibitors Production Value Market Share by Application in 2021
Figure 44. Stomach Cancer
Figure 45. Liver Cancer
Figure 46. Kidney Ccancer
Figure 47. Bladder Cancer
Figure 48. Cervical Cancer
Figure 49. Other
Figure 50. World PD-1 and PDL-1 Inhibitors Production Market Share by Application (2017-2028)
Figure 51. World PD-1 and PDL-1 Inhibitors Production Value Market Share by Application (2017-2028)
Figure 52. World PD-1 and PDL-1 Inhibitors Average Price by Application (2017-2028) & (US$/Unit)
Figure 53. Manufacturing Cost Structure Analysis of PD-1 and PDL-1 Inhibitors in 2021
Figure 54. Manufacturing Process Analysis of PD-1 and PDL-1 Inhibitors
Figure 55. PD-1 and PDL-1 Inhibitors Industrial Chain
Figure 56. Distribution Channel Breakdown for PD-1 and PDL-1 Inhibitors Shipments (%): 2017-2028
Figure 57. Direct Channel Pros & Cons
Figure 58. Indirect Channel Pros & Cons
Figure 59. Methodology
Figure 60. Research Process and Data Source
